Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-08-31 Sale |
2021-09-02 8:27 pm |
Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director |
37,864 | $34.08 | $1,290,550 | 96,428 (Indirect) |
View |
| 2021-08-31 Sale |
2021-09-02 8:20 pm |
Repare Therapeutics Inc. | RPTX | Bonita David P Director |
37,864 | $34.08 | $1,290,550 | 96,428 (Indirect) |
View |
| 2021-08-26 Sale |
2021-08-30 6:37 pm |
Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director |
18,073 | $34.07 | $615,748 | 97,542 (Indirect) |
View |
| 2021-08-26 Sale |
2021-08-30 6:33 pm |
Repare Therapeutics Inc. | RPTX | Bonita David P Director |
18,073 | $34.07 | $615,748 | 97,542 (Indirect) |
View |
| 2021-08-23 Sale |
2021-08-25 8:43 pm |
Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director |
18,215 | $34.17 | $622,426 | 98,074 (Indirect) |
View |
| 2021-08-23 Sale |
2021-08-25 8:36 pm |
Repare Therapeutics Inc. | RPTX | Bonita David P Director |
18,215 | $34.17 | $622,426 | 98,074 (Indirect) |
View |
| 2021-08-17 Sale |
2021-08-25 8:25 pm |
Repare Therapeutics Inc. | RPTX | Bonita David P Director |
20,328 | $34.1 | $693,210 | 98,610 (Indirect) |
View |
| 2021-08-16 Sale |
2021-08-20 4:24 pm |
Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Science Officer |
15,000 | $33.99 | $509,886 | 20,533 (Direct) |
View |
| 2021-08-17 Sale |
2021-08-19 8:55 pm |
Repare Therapeutics Inc. | RPTX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC ORBIMED CAPITAL LLC Director |
20,328 | $34.1 | $693,210 | 98,610 (Indirect) |
View |
| 2021-08-17 Sale |
2021-08-19 8:49 pm |
Repare Therapeutics Inc. | RPTX | Bonita David P Director |
20,328 | $34.1 | $693,210 | 98,610 (Indirect) |
View |
| 2021-07-09 Sale |
2021-07-13 4:22 pm |
Repare Therapeutics Inc. | RPTX | Foley Todd Director |
27,351 | $33.55 | $917,678 | 2,242,636 (Indirect) |
View |
| 2021-07-09 Sale |
2021-07-13 4:21 pm |
Repare Therapeutics Inc. | RPTX | GADICKE ANSBERT 10% Owner |
62,079 | $33.55 | $2,082,868 | 3,882,485 (Indirect) |
View |
| 2021-06-28 Sale |
2021-06-30 5:54 pm |
Repare Therapeutics Inc. | RPTX | Segal Lloyd Mitchell President and CEO |
1,542 | $35.61 | $54,911 | 99,466 (Indirect Direct) |
View |
| 2021-06-28 Sale |
2021-06-30 5:26 pm |
Repare Therapeutics Inc. | RPTX | Foley Todd Director |
8,460 | $34.06 | $288,136 | 2,269,987 (Indirect) |
View |
| 2021-06-28 Sale |
2021-06-30 5:25 pm |
Repare Therapeutics Inc. | RPTX | GADICKE ANSBERT 10% Owner |
19,200 | $34.06 | $653,925 | 3,944,564 (Indirect) |
View |
| 2021-06-24 Sale |
2021-06-28 4:08 pm |
Repare Therapeutics Inc. | RPTX | Foley Todd Director |
12,640 | $33.51 | $423,620 | 2,278,447 (Indirect) |
View |
| 2021-06-24 Sale |
2021-06-28 4:07 pm |
Repare Therapeutics Inc. | RPTX | GADICKE ANSBERT 10% Owner |
28,688 | $33.51 | $961,457 | 3,963,764 (Indirect) |
View |
| 2021-06-21 Sale |
2021-06-23 5:38 pm |
Repare Therapeutics Inc. | RPTX | Foley Todd Director |
18,859 | $34.36 | $647,950 | 2,291,087 (Indirect) |
View |
| 2021-06-21 Sale |
2021-06-23 5:38 pm |
Repare Therapeutics Inc. | RPTX | GADICKE ANSBERT 10% Owner |
42,798 | $34.36 | $1,470,441 | 3,992,452 (Indirect) |
View |
| 2021-06-17 Sale |
2021-06-21 4:08 pm |
Repare Therapeutics Inc. | RPTX | Foley Todd Director |
18,294 | $33.77 | $617,762 | 2,309,946 (Indirect) |
View |
| 2021-06-17 Sale |
2021-06-21 4:06 pm |
Repare Therapeutics Inc. | RPTX | GADICKE ANSBERT 10% Owner |
41,518 | $33.77 | $1,402,002 | 4,035,250 (Indirect) |
View |
| 2021-06-14 Sale |
2021-06-16 5:10 pm |
Repare Therapeutics Inc. | RPTX | Foley Todd Director |
2,743 | $33.25 | $91,213 | 2,328,240 (Indirect) |
View |
| 2021-06-14 Sale |
2021-06-16 5:09 pm |
Repare Therapeutics Inc. | RPTX | GADICKE ANSBERT 10% Owner |
6,227 | $33.25 | $207,066 | 4,076,768 (Indirect) |
View |
| 2021-06-09 Sale |
2021-06-10 6:35 pm |
Repare Therapeutics Inc. | RPTX | Segal Lloyd Mitchell President and CEO |
1,576 | $35 | $55,160 | 101,008 (Indirect Direct) |
View |
| 2021-06-08 Sale |
2021-06-10 4:05 pm |
Repare Therapeutics Inc. | RPTX | Foley Todd Director |
27,067 | $34.05 | $921,529 | 2,330,983 (Indirect) |
View |
| 2021-06-08 Sale |
2021-06-10 4:04 pm |
Repare Therapeutics Inc. | RPTX | GADICKE ANSBERT 10% Owner |
61,430 | $34.05 | $2,091,457 | 4,082,995 (Indirect) |
View |
| 2021-06-03 Sale |
2021-06-07 6:40 pm |
Repare Therapeutics Inc. | RPTX | Foley Todd Director |
25,622 | $32.01 | $820,274 | 2,358,050 (Indirect) |
View |
| 2021-06-03 Sale |
2021-06-07 6:39 pm |
Repare Therapeutics Inc. | RPTX | GADICKE ANSBERT 10% Owner |
58,149 | $32.01 | $1,861,612 | 4,144,425 (Indirect) |
View |
| 2021-06-03 Sale |
2021-06-07 6:36 pm |
Repare Therapeutics Inc. | RPTX | Segal Lloyd Mitchell President and CEO |
41,000 | $31.11 | $1,275,367 | 386,267 (Indirect Direct) |
View |
| 2021-05-28 Sale |
2021-06-02 5:40 pm |
Repare Therapeutics Inc. | RPTX | Foley Todd Director |
16,786 | $32.47 | $545,041 | 2,383,672 (Indirect) |
View |
| 2021-05-28 Sale |
2021-06-02 5:39 pm |
Repare Therapeutics Inc. | RPTX | GADICKE ANSBERT 10% Owner |
38,098 | $32.47 | $1,237,042 | 4,202,574 (Indirect) |
View |
| 2021-05-25 Sale |
2021-05-27 7:55 pm |
Repare Therapeutics Inc. | RPTX | Foley Todd Director |
16,989 | $32.82 | $557,635 | 2,400,458 (Indirect) |
View |
| 2021-05-25 Sale |
2021-05-27 7:41 pm |
Repare Therapeutics Inc. | RPTX | GADICKE ANSBERT 10% Owner |
38,559 | $32.82 | $1,265,633 | 4,240,672 (Indirect) |
View |
| 2021-05-21 Sale |
2021-05-24 8:13 pm |
Repare Therapeutics Inc. | RPTX | Foley Todd Director |
143,141 | $34.75 | $4,974,688 | 2,417,447 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-08-05 Other |
2021-08-09 4:44 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Versant Ventures V LLC Versant Ophthalmic Affiliates I L.P. Versant Affiliates Fund V L.P. Versant Venture Capital V (Canada) LP Versant Ventures V GP-GP (Canada) Inc. Versant Venture Capital V L.P. Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Ventures V (Canada) L.P. 10% Owner |
156,610 | $0 | 4,924,800 (Indirect) |
View |
| 2021-08-05 Other |
2021-08-09 4:43 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Jerel Davis Director 10% Owner |
156,629 | $0 | 4,936,595 (Indirect) |
View |
| 2021-08-05 Other |
2021-08-09 4:42 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner |
156,610 | $0 | 5,156,011 (Direct) |
View |
| 2021-06-04 Exercise |
2021-06-07 6:36 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Segal Lloyd Mitchell President and CEO |
5,000 | $1.637 | 386,267 (Direct) |
View |
| 2021-06-04 Exercise |
2021-06-07 6:36 pm |
N/A 2027-06-22 |
Repare Therapeutics Inc. | RPTX | Segal Lloyd Mitchell President and CEO |
5,000 | $0 | 386,267 (Direct) |
View |
| 2021-06-01 Other |
2021-06-03 4:36 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Jerel Davis Director 10% Owner |
77,256 | $0 | 4,854,911 (Indirect) |
View |
| 2021-06-01 Other |
2021-06-03 4:32 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner |
77,247 | $0 | 5,226,427 (Direct) |
View |
| 2021-06-01 Other |
2021-06-03 4:31 pm |
N/A N/A |
Repare Therapeutics Inc. | RPTX | Versant Ventures V LLC Versant Ophthalmic Affiliates I L.P. Versant Affiliates Fund V L.P. Versant Venture Capital V (Canada) LP Versant Ventures V GP-GP (Canada) Inc. Versant Venture Capital V L.P. Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Ventures V (Canada) L.P. 10% Owner |
77,247 | $0 | 4,843,145 (Indirect) |
View |